SOPHIA ANTIPOLIS – CMR 2018, a highly anticipated event focusing on cardiovascular magnetic resonance (CMR), is set to showcase the latest advancements in the field and their impact on patient care and outcomes.

Organized jointly by the European Association of Cardiovascular Imaging (EACVI) and the Society for Cardiovascular Magnetic Resonance (SCMR), CMR 2018 will take place from January 31 to February 3 at the Centre Convencions Internacional de Barcelona (CCIB) in Barcelona, Spain.

Under the theme “Improving Clinical Value by Technical Advances,” CMR 2018 aims to highlight the significant contributions of new developments in CMR to patient care. With a focus on higher quality images and faster scan times, the event emphasizes how these advancements enhance disease understanding, diagnosis, and treatment while improving patient experience.

Renowned experts in imaging and arrhythmias, including Professor Josep Brugada and ESC President Professor Jeroen Bax, will lead discussions on topics such as sudden cardiac death prevention and the role of CMR in detecting heart disease in women.

Dr. Jose Palomares, representing EuroCMR, emphasized the conference’s role in providing up-to-date information and insights into various disease areas. Dr. Allison Hays, representing SCMR, highlighted CMR’s suitability in understanding heart attacks in women.

A key focus of the event will be on artificial intelligence, with a dedicated session on deep learning/machine learning. Leading experts, including Professor Daniel Rueckert, will explore how these technologies are revolutionizing CMR and expanding its capabilities.

Additionally, CMR’s role in detecting metabolic changes in the heart, diagnosing coronary artery disease, and predicting heart failure will be discussed. Novel techniques like T1 mapping and ischaemia imaging will be featured, along with clinical trial results demonstrating CMR’s cost-effectiveness in improving patient outcomes.

Dr. Palomares emphasized CMR 2018’s role in highlighting key developments in cardiovascular magnetic resonance, while Dr. Hays underscored the event’s focus on applying CMR in a clinically meaningful way to enhance healthcare.